Back to Journals » International Journal of Women's Health » Volume 3

Fetal gender ratio in recurrent miscarriages

Authors Del Fabbro A, Driul L, Omar Anis, Londero AP, Bertozzi S, Bortotto L, Marchesoni D

Published 20 July 2011 Volume 2011:3 Pages 213—217

DOI https://doi.org/10.2147/IJWH.S20557

Review by Single anonymous peer review

Peer reviewer comments 2



Anna Del Fabro1, Lorenza Driul1, Omar Anis1, Ambrogio P Londero1, Serena Bertozzi2, Livio Bortotto3, Diego Marchesoni1
1Clinic of Obstetrics and Gynecology, 2Clinic of Surgery, 3Unit of Genetics, University Hospital of Udine, Udine, Italy

Background: The purpose of this study was to evaluate the gender ratio and incidence of chromosomal anomalies in the products of conception (POC) from recurrent miscarriages.
Methods: We determined the karyotypes of POC from patients with recurrent spontaneous miscarriages between 1999 and 2009.
Results: In total, 313 specimens were successfully karyotyped, with a median gestational age of 10 weeks at miscarriage (interquartile range 8–13); 199 (64%) were females and 114 (36%) were males. In total, 121 (39%) had abnormal karyotypes, the most prevalent of which were chromosome 21 and 16 trisomies, triploidy, and monosomy X.
Conclusion: Our findings suggest that female POC might be more susceptible to recurrent miscarriages than male ones during embryogenesis, implantation, and initial fetal development.

Keywords: fetal gender, recurrent miscarriages, karyotype anomalies

Creative Commons License © 2011 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.